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Abstract.  Differential trafficking of glucose trans- 
porters contributes significantly to the establishment of 
a cell's capacity for hormone-regulatable hexose up- 
take. In the true insulin-sensitive peripheral target tis- 
sues, muscle and adipose, the transporter isoform 
GLUT1  residues on the cell surface and interior of the 
cell whereas the highly homologous isoform GLUT4 
displays virtually exclusive intracellular sequestration, 
allowing the latter to redistribute to the cell surface in 
response to hormone. These patterns are equally pro- 
nounced in cells into which the transporters have been 
introduced by DNA-mediated gene transfer, suggesting 
that signals for isoform-specific sorting are recognized 
in diverse cell types. To determine the primary se- 
quences responsible for the characteristic distributions, 
chimeric transporters were constructed in which 
reciprocal domains were exchanged between GLUT1 
and GLUT4. In addition, a non-disruptive, species- 
specific epitope "tag" was introduced into a neutral re- 
gion of the transporter to allow analysis of reciprocal 
chimeras using a single antibody. These recombinant 
transporters were stably expressed in HIH 3T3 and 
PC12  cells by retrovirus-mediated gene transfer, and 
were localized by indirect immunofluorescence and la- 
ser scanning confocal microscopy, as well as by stain- 
ing of plasma membrane sheets  prepared from these 
cells. The results indicate that the carboxy-terminal 30 
amino acids are primarily responsible for the differen- 
tial targeting of the glucose transporter isoforms 
GLUT1  and GLUT4, though there is a lesser addi- 
tional contribution by the amino-terminal 183 amino 
acids. 
xposuaE  of muscle  and  adipose  tissue  to  insulin 
stimulates a rapid and dramatic increase in glucose 
uptake, primarily by altering the subcellular distribu- 
tion of glucose transporter  proteins  (for reviews see refer- 
ence 4).  At least  two of the five hexose carder isoforms 
identified to date are expressed in these cells and, although 
they were highly homologous in their primary and predicted 
secondary structures, are targeted to distinct subcellular lo- 
cations  (3,  19). In the basal  state,  the widely expressed 
GLUT1 is distributed to both the plasma membrane and the 
interior of the cell,  whereas  GLUT4, the transporter  ex- 
pressed exclusively in true insulin-responsive cell types, is 
sequestered in an intracellular  storage vesicle (4). This ob- 
servation suggests that differences intrinsic  to the GLUTI 
and GLUT4 proteins dictate their differential sorting. Thus, 
the  current  translocation  model  to  describe  the  insulin- 
induced increase in glucose uptake in fat and muscle cells 
proposes that insulin evokes a redistribution of GLUT4, and 
to a lesser extent GLUTI, from the interior of the cell to the 
plasma membrane, thereby increasing the glucose transport 
capacity of the cell. This selective enrichment of GLUT4 at 
the cell  surface  is  reversible,  as  removal of the hormone 
returns this isoform to its storage site in the interior of the 
cell (28, 31). 
Support for such a translocation model derives from sev- 
eral studies, including the demonstration by immunoelectron 
microscopy (immunoEM) that GLUT4 localized to tubulo- 
vesicular  elements of the TGN (11) and endosomes  of rat 
brown adipose tissue shifts to the plasma membrane upon 
treatment  with  insulin  (28). These  findings  have been 
confirmed by similar studies in isolated rat adipocytes, rat 
skeletal muscle, and rat cardiac muscle (25, 27, 29). Surface 
labeling of rat adipocytes with a photoactive hexose analog 
has allowed quantification of  this redistribution, with insulin 
stimulation increasing GLUT1 labeling of the plasma mem- 
brane  fivefold  and  GLUT4  15-20-fold  (15). In  mouse 
3T3-Ll-cultured  adipocytes, as in rat fat cells, GLUT1 and 
GLUT4 display distinct staining patterns and differences in 
magnitude of hormone-dependent  recruitment  (6, 22). 
Several lines of evidence support the proposition that the 
primary structures of GLUTI and GLUT4 contain the infor- 
mation necessary  for their differential  subcellular  target- 
ing. When cDNAs were introduced into minimally insulin- 
responsive cell lines, the transporters were found in distinct 
subcellular locales: predominantly perinuclear  for GLUT4 
and cell surface for GLUT1. The two isoforms have been ex- 
pressed in mouse 3T3-L1 and NIH 3T3 fibroblasts (12, 17), 
hamster CHO cells (23, 26), human HepG2 cells (12), and 
©  The Rockefeller University Press, 0021-9525/93/10/137/11  $2.00 
The Journal of Cell Biology, Volume 123, Number I, October 1993 137-147  137 rat PCI2 cells (18). Even in such diverse cell types, each iso- 
form shows a  characteristic pattern of localization. These 
studies suggest that GLUTI and GLUT4 are recognized in 
distinct ways by the trafficking pathways of the cell and that 
the machinery necessary to sequester GLUT4 in an intracel- 
lular pool is present in disparate cell types. Whether GLUT4 
resides in the same organelle in insulin-responsive and non- 
responsive cells is unclear, as are the mechanisms involved 
in sorting GLUT4 to this ill-defined compartment. Nonethe- 
less, these results demonstrate that the sequences of these 
transporters must contain information capable of directing 
them to different cellular locales. 
In an effort  to identify the primary sequence(s) responsible 
for sorting GLUT1 and GLUT4 to different locations within 
the  cell,  we  constructed  chimeric  transporters  in  which 
reciprocal domains  were exchanged between the two iso- 
forms.  These recombinant transporters were expressed in 
identical cellular contexts and their localization analyzed. 
Piper et al. (23) and Asano et al. (2) have recently published 
analogous  studies  aimed  at  identifying  the  targeting  se- 
quence of GLUT4, but obtained conflicting results. We ap- 
proached this problem by using stable expression in two cell 
lines of immunologically "tagged" chimeras, and concluded 
that both the amino and carboxy domains contribute to the 
targeting  of the transporters,  with the latter predominant. 
Materials and Methods 
DNA Constructs 
The retrovirai expression vector pDO-R (renamed pDOJ, a gift of Dr. Con- 
nie Cepko, Harvard Medical School, Boston, MA) has been described pre- 
viously, as have the plasmids pDOJ-GT (the rat GLUTI cDNA inserted into 
DOJ) and pDOJ-SM (the rat GLUT4 cDNA inserted into DOJ) (17). Chi- 
meric transporters were constructed by fusing portions of the GLUT1 and 
GLUT4 cDNAs at common restriction sites either present in the wild-type 
sequence or engineered by polymerase chain reaction-based  mutagenesis 
(13, 14, 30). All sequences produced by the polymerase chain reaction were 
confirmed  using the Sequenase polymerase  (United  States  Biochemical 
Corp., Cleveland, OH) according to the manufacturer's instructions.  The 
nncleotide and amino acid numberings used below are according to pub- 
lished sequences of rat GLUT1 and GLUT4 (3, 5). 
The general strategy for the construction of  chimeric transporters is sum- 
marized in Fig. 1. A BsmI site (see Fig. 1 M) present in the GLUT4 eDNA 
at nuclcotide 653 (amino acid 183) was introduced into the GLUTI eDNA 
at nucleotide 707 (amino acid 167) by changing nucleotide G708 to C and 
nucleotide C711 to T. The HindlII  site (see Fig.  1 D) at nucleotide 895 
(amino acid 230) in the GLUTI  eDNA was engineered into the GLUT4 
eDNA (nucleotide 841, amino acid 246) by changing the following nucleo- 
tides: C841 to A, G842 to A, C843 to G, and G846 to T. The ApaI site 
(see Fig.  1 A) at nncleotide 1403 (amino acid 399) of the GLUTI  eDNA 
was introduced  into  the GLUT4  eDNA  (amino acid  415) by changing 
nucleotide C1347 to G. The BglU site (see Fig. 1 B) present in the GLUT4 
eDNA at nucleotide 1538 (amino acid 478) was added to the GLUT1 eDNA 
(amino acid 462) by changing nucleotide G1597 to T. The human epitope 
(see Fig. 1 H) was engineered into the rat GLU'H eDNA by changing amino 
acid 239 from Arg to His (nucleotides C921 to T, CO23 to A, and A924 
to T).  The naming of the chimeras  and the amino acid contributions of 
GLUTI and GLUT4 to each are shown in Fig. 1. In addition, all constructs 
bearing the human GLUTI epitope also contained the identical 3' untrans- 
lated region (3'-UTR) I contributed by the rat GLUTI eDNA, independent 
of the source of the carboxy-terminai coding sequences. This was accom- 
plished by overlapping polymerase  chain reaction,  in which the GLUT1 
3'-UTR was added immediately after the GLUT4 termination codon (14, 16). 
1.  Abbreviations  used  in  this  paper:  PM,  plasma  membrane;  Y-UTR, 
3'-untranslated region; WGA, wheat germ agglutinin. 
Cell Culture and Gene Transfer 
NIH  3T3  and  Psi2  mouse  fibroblasts  (21) were  grown  in  DME  sup- 
plemented with  10% calf serum whereas HeLa cells were maintained in 
DME plus 10% FBS. The rat pheochromocytoma cell line PC12 (10) was 
grown in DME containing 10% horse serum and 5% FBS on tissue culture 
plates coated with rat tall collagen (Biomedical Technologies, Stoughton, 
MA). Cells transfected or infected with retrovirus containing the neo resis- 
tance gene were maintained in medium supplemented with 200 #g/ml active 
concentration Geneticin ((3418; GIBCO-BRL, Gaithersburg, MD). Retro- 
virus was harvested from pools of stably transfected Psi2 cells as described 
previously (17) and used to infect NIH 3T3 and PC12 ceils. Colonies of 
G418-resistant cells were identified 10-14 d after retrovirus infection and 
were expanded singularly as clones or together as pools in 200/~g/ml G418. 
Supernatant from hybridoma cells producing mAbG3 (1; a gift of  Dr. Gus 
Lienhard, Dartmouth Medical School, Hanover, NH), a mAb specific for 
human GLUT1, was used undiluted for immunofluorescence or diluted 1:2 
with 1% low-fat dried milk powder (Carnation Co., Los Angeles, CA) for 
Western blotting. 
Analysis of  Proteins 
Total cellular membranes were prepared and subjected to SDS-PAGE and 
Western blot analysis as described (17) except that 1% low-fat dried milk 
powder was used as a blocking agent. Blots were quantitated using a Molec- 
ular  Dynamics  (Sunnyvale, CA) phosphorimager  equipped  with  Image- 
Quant software. 
NIH 3T3 cells plated on glass coverslips 2 d before an experiment were 
washed with PBS and fixed in 3 % paraformaidehyde for immunnflnores- 
cence using rabbit polyclonal antisera directed against the carboxy terminus 
of GLUT1 or GLUT4 (17). For some experiments, anisomycin (100 #M) 
or cycloheximide (20 #g/ml) was present for 0-4 h before fixation. PC12 
cells were plated on poly-D-lysine-coated coverslips and the following day 
10 ng/mi NGF (purchased from the Director of Research at the University 
of Michigan, Flint, MI) was added to the medium. After 2 d, the cells were 
fixed with 3 % paraformaldehyde and processed for immunofluorescence. 
All coverslips were mounted in Mowiol and the cells visualized with a Zeiss 
Axiophot fluorescence microscope (Carl Zeiss, Oberkochen, Germany) or 
a  scanning laser  confocal microscope  (MRC600;  BioRed Laboratories, 
Cambridge, MA), as indicated. 
Preparation  and analysis of plasma  membrane  (PM)  sheets was per- 
formed as described previously (9, 23, 24). Briefly, cells were grown on 
poly-D-lysine-coated coverslips in 35 mm wells for 2 d or until confluent. 
The cells were washed twice with ice-cold buffer A (50 mM Hepes, pH 7.2, 
100 mM NaCI) and twice with ice-cold buffer B (20 mM Hepes, pH 7.2, 
100 mM KCI, 2 mM CaC12,  1 mM MgCI2, 10 #M leupeptin,  2 t~g/ml 
trypsin inhibitor, 0.5 mM benzamidine). Each well was sonified in ice-cold 
buffer B for 3 s using a Branson 250 Sonifler (Branson Ultrasonics Corp., 
Danbury, CT) with a 0.8-mm tapered microtip placed 1 cm above the cover- 
slip. The adherent PM sheets were then washed twice with ice-cold buffer 
B, fixed with 3 % paraformaldehyde and processed for immunnfluorescence 
as above, except without detergent.  After incubating the coverslips with 
mAbG3 and rhedamine-conjugated  goat anti-mouse secondary antibody 
(Tago, Inc., Burlingame, CA), the sheets were labeled for 15 rain with 0.2 
#g/ml FITC-conjugated wheat germ agghitinin (F1TC-WGA; Vector Lab- 
oratories  Inc., Burlingame, CA). 
Results 
Analysis of Group I Chimeric Transporters 
As an initial approach, we divided the transporters into four 
domains based on convenient unique restriction sites which 
were present in one transporter and were engineered at the 
corresponding location into the eDNA encoding the other 
isoform. These first sites chosen were BsmI (M) located at 
sequences encoding membrane spanning region 5  (MS5), 
HindIII (D) in the large intracellular loop, and ApaI (A) be- 
tween MS10 and MSll (Fig. 1, Group I). Chimeric eDNAs 
constructed by conventional subcloning techniques were in- 
serted into a retroviral expression vector and the viral super- 
natant was used to infect two different cell lines, mouse NIH 
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brane topology of the glucose transporters (top). The indicated re- 
striction sites BsmI (M), Hindm (D), ApaI (A), and BgllI (B) 
were used to exchange portions of  the GLUT1 and GLUT4 cDNAs. 
H designates the amino acid of GLUT1 altered to create the human 
epitope  "tag"  (see  text).  The contribution  of GLUT1 (n)  and 
GLUT4 (m) to each chimera is shown schematically in the bottom 
half  of  the figure. Group I chimeras were constructed by exchanging 
segments of the transporters at sites M, D, and A and were named 
by a four digit code corresponding to the contribution of each iso- 
form to the four domains. In Group II, the chimeras were named 
according to the contribution of GLUTI or GLUT4 to the segments 
before and after the Apal site (A). For the naming of Group m 
chimeras, H designates the human epitopes and B represents the 
BlgII site. Chimeras of Groups I and II contain the Y-UTR of the 
isoform contributing the carboxy-termina130 amino acids whereas 
the chimeras  in Group III all contain the GLUT1 Y-UTR. MS, 
membrane spanning. 
3T3 and rat PC12 cells. Stable G418-resistant clones of each 
construct were expanded (NIH  3T3  cells)  or pooled and 
differentiated with NGF (PC12 cells) and analyzed by in- 
direct immunofluorescence microscopy using  anti-peptide 
antibodies reactive with the carboxy terminus of the chi- 
meras. A representative clone of each construct in NIH 3"1"3 
cells is shown in Fig. 2; reciprocal chimeras are shown adja- 
cent to each other. Wild-type GLUT1 (JGT) was found in a 
peripheral distribution in both cell types, consistent with cell 
surface  expression  (Fig.  2,  A  and  B),  whereas  GLUT4 
(JSM)  was localized to the perinuclear region in NIH3T3 
cells (Fig. 2 C) and to the perinuclear region of the cell body 
and the distal portions of the neuronal processes in PC12 
cells (Fig. 2 D), as has been previously reported (18).  In- 
direct immunofluorescence of ceils expressing the chimeric 
transporters 4441, 4411, and 4111 with or-GLUT1 displayed 
staining of both the perinuclear region and the cell surface, 
as well as some staining in the termini of  the neurites in PC12 
ceils (Fig. 2, E, F, I, J, M, and N). These results indicate 
that the amino-terminal third of GLUT4 is capable of divert- 
ing some of GLUT1 from the plasma membrane to an intra- 
cellular site.  Localization of the reciprocals of these chi- 
meras  (1114,  1144,  and  1444)  with  or-GLUT4  showed 
predominant staining in the perinuclear region of both cell 
types, and in the ends of the neuronal processes in PC12 
cells, with minimal labeling of the plasma membrane (Fig. 
2, G, H, K, L, O, and P). When the amino- and the carboxy- 
termini were contributed by the same isoform, i.e., chimeras 
1411 and 4144, the apparent subcellular distribution was in- 
distinguishable from that of wild-type GLUTI and GLUT4, 
respectively, in both NIH 3T3 and PC12 cells (Fig. 2, Q-T). 
Group H Chimeric Transporters Further Delineate 
the Carboxy-terminal Signal 
The above data suggest that the carboxy-terminal region is 
important for the differential sorting of GLUT1 and GLUT4 
in at least two distinct cell types. To further resolve the loca- 
tion of relevant sequences in this region of the transporter, 
a  BglII site (Fig.  1, B) located in sequences encoding the 
amino acid 31  residues from the end of GLUT4 was en- 
gineered  into  the  corresponding  position  of the  GLUT1 
cDNA. Using this site, as well as the ApaI site (A) following 
MS10,  chimeras were constructed in which either only the 
last two MS regions or only the cytoplasmic carboxy termi- 
nus of each transporter was replaced by the corresponding 
domain of the other isoform (Fig. 1, Group 1I). The eDNAs 
were introduced into NIH 3T3 cells via retroviral infection 
and stable G418-resistant clones were analyzed by indirect 
immunofluorescence microscopy. Two representative clones 
of each chimera are shown in Fig.  3.  The substitution of 
MSll and MS12 of GLUT1 by that of GLUT4 did not alter 
its localization to the cell surface (Fig. 3, A and B; chimera 
1A41), and the replacement of this region of GLUT4 by that 
of GLUTI did not affect its perinuclear distribution (Fig. 3, 
C  and  D;  chimera  4A14).  However,  when  the  carboxy- 
terminal 30 amino acids of GLUTI were replaced by the cor- 
responding domain of GLUT4, the chimera was localized 
predominantly in a perinuclear distribution similar to that of 
GLUT4 (Fig. 3, G and H; chimera 1A/4). The reciprocal chi- 
mera, 4A41, displayed an "intermediate" phenotype, in which 
the transporter showed staining at the cell surface as well as 
intracellularly (Fig.  3, E  and F). 
Introduction of a Species-specific Epitope Tag 
The experiments described thus far appeared to identify a 
prominent determinant of subcellular trafficking in the car- 
boxy terminus of the transporters.  Since this region of the 
Verhey et al. Chimeric  Glucose Transporters  139 Figure 2. Indirect immunofluorescence of group I chimeric transporters  in NIH 3T3 and PC12 cells. Clones of NIH 3T3 cells and pools 
of NGF-treated PCI2 cells stably infected with retrovirus containing GLUT1 (JGT),  GLUT4 (JSM), or the indicated chimeric cDNAs 
were fixed, permeabilized,  and stained with an antibody to the GLUT1 carboxy terminus (A, B, E, F, I, J, M, N, Q, and R) or an antibody 
to the GLUT4 carboxy terminus (C, D, G, H, K, L, O, P, S, and T). For each antibody, the same photographic  and printing conditions 
were used for all chimeras.  Bar, 20 #M. 
protein is the same as that recognized by the antibodies, we 
were wary of artifacts resulting from the inability to analyze 
reciprocal chimeras with identical immunological reagents. 
Thus, we elected to "tag" the chimeras with a  neutral epi- 
tope. As shown in Figs. 2 and 3, the exchange of sequences 
in the middle portion of the transporters, including the large 
cytoplasmic loop, had no effect on their subcellular distribu- 
tions.  A  mAb has been raised against the human GLUT1 
transporter  (mAbG3)  which  recognizes  amino acids  231- 
246 in this central loop of the human GLUT1 protein, but 
does not react with the rat GLUT1 protein (1, 8). These spe- 
cies differ by only a  single amino acid in this region.  We 
therefore changed residue 239 in the rat GLUT1 cDNA from 
Arg to His, as it occurs in the human transporter, naming the 
mutant 1HB1 (Fig. 1). Immunofluorescence microscopy con- 
firmed that mAbG3 recognized the glucose transporter en- 
dogenous to the human cell line HeLa (Fig. 4 A), but it did 
not  detect  either  the  endogenous  transporter  present  in 
The Journal of Cell Biology, Volume  123, 1993  140 Figure 3. Indirect immunofluorescence of group II chimeric transporters in NIH3T3 cells. Clones of NIH 3T3 cells stably infected with 
retrovirus containing the indicated chimeric cDNAs were fixed, permeabilized and stained with an antibody to the GLUT1 carboxy terminus 
(A, B, E, and F) or an antibody to the GLUT4 carboxy terminus (C, D, G, and H). For each antibody, the same photographic and printing 
conditions were used for all chimeras. Bar, 20 ~M. 
mouse NIH 3T3 ceils (Fig. 4  C) or the rat GLUT1 protein 
expressed in NIH 3T3 cells (Fig. 4 E, JGT). However, the 
antibody did recognize the rat GLUTI protein in which the 
human epitope had been inserted, as assayed after introduc- 
tion of the 1HB1 transporter into NIH 3T3 cells (Fig. 4 G). 
For comparison, the same cells were labeled with the anti- 
peptide antibody directed against the carboxy terminus of 
GLUT1.  This antisera recognized the GLUT1 protein re- 
gardless  of species:  the human transporter in  HeLa cells 
(Fig. 4 B), the mouse GLUT1 present in NIH 3T3 cells (Fig. 
4 D), and the overexpressed rat GLUT1 without (Fig. 4 F, 
JGT) and with (Fig. 4 H,  1HB1) the human epitope. Thus, 
this single amino acid change in the rat GLUTI sequence al- 
lowed detection of the transporter at a site not implicated in 
sorting of the isoforms. 
Analysis of the Group III Chimeric Transporters 
Containing the Epitope Tag 
Chimeric transporters were constructed in which the central 
portions were contributed by the 1HB1 mutant and the ends 
represented all possible combinations of GLUT1 and GLUT4 
(Fig.  1, Group l~I).  In addition, to reduce potential differ- 
ences in levels of expression due to variations in mRNA sta- 
bility, these constructs were designed to contain an identical 
3'-UTR contributed by the rat GLUT1 eDNA. At least eight 
clones of NIH 3T3 ceils infected with retrovirus encoding 
each of the "tagged" chimeras were expanded and the levels 
of transporter determined by Western blotting of total cellu- 
Figure 4.  Double  label  indirect  immunofluorescence shows the 
specificity of mAbG3 and the human epitope "tag." HeLa cells (A 
and B), untransfected NIH 3T3 cells (Cand D), NIH 3"1"3  cells ex- 
pressing rat GLUTI (JG~, E and F) and NIH 3T3 cells expressing 
the "tagged' chimera 1HB1 (G and H) were fixed, permeabilized, 
and  stained  for double  immunofluoreseence with  mAbG3  and 
rhodamine-conjugated goat anti-mouse antibody (A, C, E, and G) 
and with an antibody to the GLUT1 carboxy terminus and F1TC- 
conjugated goat anti-rabbit antibody (B, D, F,, and H). For each an* 
tibody, the same photographic and printing conditions were used 
for all cell lines. Bar, 20/~M. 
Verhey et al. Chimeric  Glucose Transporters  141 Figure 5. Western blot of clones of NIH 3T3 ceils expressing the 
"tagged" chimeras. Total membranes (50 #g) prepared from NIH 
3T3 cells, HeLa cells, NIH 3T3 cells expressing GLUT1 (JGT), 
NIH 3T3 cells expressing GLUT4 (JSM), and from clones of NIH 
3T3 cells infected with retrovirus containing the cDNAs of the 
"tagged" chimeras were subject to SDS-PAGE  and Western blotting 
with mAbG3 (A), an antibody against the GLUT1 carboxy termi- 
nus (B), or an antibody to the GLUT4 carboxy terminus (C). 
lar membranes with mAbG3.  Two clones expressing each 
construct were selected based on the expression of approxi- 
mately the same amount (within twofold variation) of recom- 
binant transporter. All four "tagged" chimeras, as well as the 
HeLa cell glucose transporter, were detected by Western blot 
with mAbG3, whereas the endogenous NIH 3T3 transporter 
was not (Fig.  5 A).  As expected,  1HBI  and 4HB1 but not 
4HB4 and 1HIM were recognized by the c~-GLUT1 carboxy- 
terminal antibody (Fig. 5 B). This antibody also recognized 
the endogenous transporter present in transfected and un- 
transfected NIH 3T3 cells (Fig. 5, B; and data not shown). 
The tx-GLUT4 carboxy-terminal  antibody detected chimeras 
4HB4 and 1HIM, but not the glucose transporter present in 
the parental  NIH 3T3 cells (data  not shown),  or in  cells 
transfected with the chimeras  1HB1 and 4HB1 (Fig.  5  C). 
NIH 3T3 cells expressing the "tagged" chimeras were used 
to compare the immunofluorescence staining patterns of the 
anti-carboxy terminal antibodies to the anti-human mAbG3. 
The  chimeras  1HB1 and  4I-IB1 were  labeled  with  the 
oL-GLUTI  antibody  and  mAbG3,  whereas  the  chimeras 
4HB4 and 1HB4 were labeled with the or-GLUT4 antibody 
and rnAbG3 (Fig. 6). In general, similar patterns were ob- 
served with both mono- and polyclonal antisera, and these 
confirmed the data presented above. II-IB1  displayed the pre- 
dominant cell surface staining characteristic of GLUT1 (Fig. 
6, A and B), whereas 4HIM showed a perinuclear localiza- 
tion identical to that of wild-type GLUT4 (Fig. 6, D and E). 
The chimera 1HB4, containing only the COOH-terminal 30 
amino acids of GLUT4, showed staining in the perinuclear 
region similar to that of 4HB4, but with the suggestion of 
some peripheral immunoreactivity not seen in cells express- 
ing either GLUT4 or 4HB4 (Fig. 6, J  and K). Analysis of 
the chimera 4HB1 showed a phenotype "intermediate" to the 
wild-type  isoforms,  with  significant  staining  of both  the 
plasma  membrane  and  the  perinuclear region  (Fig.  6,  G 
and H). 
One possible explanation for the perinuclear staining was 
that the chimeric transporters had accumulated in a biosyn- 
thetic compartment such as the Golgi complex. To address 
this issue, cells were exposed to an inhibitor of protein syn- 
thesis before localization of the chimeras by immunofluores- 
cence with mAbG3. Treatment with anisomycin for 1 h did 
not alter the distribution of the transporters (Fig. 6, C, F, I, 
and L). Identical results were obtained after incubation in 
anisomycin for up to 4 h and when protein synthesis was in- 
hibited by cycloheximide (data not shown). 
As an alternative method for localizing transporters to the 
cell surface, we and others have adapted a protocol devel- 
oped  for directly visualizing  the  cytoplasmic face of the 
plasma membrane (9, 20, 23, 24). Cells grown on poly-D- 
lysine-coated coverslips were sonified to remove essentially 
all intracellular contents, leaving "sheets" of PM firmly at- 
tached to the cover slips. These PM sheets were fixed with 
paraformaldehyde and probed with antisera directed against 
the cytoplasmic epitope "tag" of the chimeric transporters. 
Since the PM sheets were difficult to visualize by phase mi- 
croscopy, they were also stained with FITC-WGA. Labeling 
of  1HB1 with  mAbG3  showed the  characteristic  GLUT1 
staining pattern in whole cells and abundant fluorescence in 
the PM sheets (Fig. 7, A-C). In contrast, rnAbG3 identified 
no transporter in PM sheets from cells expressing 4HB4, in 
spite of the typical perinuclear staining in whole cells and 
the presence of sheets on the coverslip as confirmed by FITC- 
WGA staining (Fig. 7, D-F).  Cells expressing the chimera 
4HB1 revealed labeling of PM sheets by mAbG3, though less 
than that of 1HB1 (Fig.  7,  G-l).  Since both cell lines ex- 
pressed similar levels of total cellular chimeric transporter, 
the less intense fluorescence of the PM sheets derived from 
4HB1 indicates a smaller percentage of chimeric transporter 
residing on the cell surface compared to 1HB1. Staining by 
mAbG3 of PM sheets prepared from 1HB4 fibroblasts was 
barely detectable (Fig. 7, J-L). 
The "tagged" chimeric transporters were also introduced 
into PC12  cells and a  similar analysis was performed on 
pools of G418-resistant cells. Indirect immunofluorescence 
microscopy with mAbG3 showed patterns of staining of in- 
tact PC12 cells expressing 1HB1 or 4HB4 identical to that 
The Journal of Cell Biology, Volume  123, 1993  142 Figure 6. Indirect immunofluorescence of the ~tngged"  chimeras in NIH 3"1"3  cells. Clones of NIH 3T3 cells expressing similar levels of 
the ~tagged  ~ chimeric transporters were fixed, permeabilized, and labeled for immunofluorescence. Chimeras 1HB1 (A and B) and 4HB1 
(G and H) were stained with an antibody to the GLUT1 carboxy terminus and FITC-conjugated goat anti-rabbit antibody (,4 and G) and 
with mAbG3 and rhodamine-conjugated goat anti-mouse antibody (B and H). Chimeras 4HB4 (D and E) and 1HB4  (Jand K) were stained 
with an antibody to the GLUT4 carboxy terminus and FITC-conjugated goat anti-rabbit  antibody (D and J) and with mAbG3 and 
rhodamine-eonjugated goat anti-mouse  antibody (E and K). For C, F, I and L, cells were incubated in 100 ttM anisomycin for 1 h at 
37°C before fixation and staining with mAbG3 and rhodamine-conjugated goat anti-mouse antibody. In parallel experiments, cells infected 
with vesicular stomatitis virus (VSV) for 3 h and treated with anisomycin displayed negligible staining of VSV G protein in the Golgi 
complex by immunofluorescence, confirming the effectiveness of the protein synthesis inhibitor (data not shown). For each antibody, the 
same photographic and printing conditions were used for each chimera.  Bar, 20 #M. 
of the wild-type GLUT1 or GLUT4, respectively (Fig. 8, E 
and I). Plasma membrane sheets prepared from PC12 cells 
expressing the "tagged" chimeras were also analyzed. Abun- 
dant labeling was seen for 1HB1 PM sheets, whereas sheets 
from cells expressing 4HB4 were not detectable with the 
same antibody (Fig.  9,  G and K, respectively). 4HB1 was 
also  localized to  the  cytoplasmic  surface  of the  isolated 
sheets, but at an abundance less than that for 1HB1 (Fig. 9 
O), and cells expressing 1HB4 showed slight labeling of PM 
sheets (Fig. 9 S). 
These cell lines were also analyzed by scanning laser con- 
focal microscopy; the optical sections shown in Fig. 8 are at 
approximately mid-nucleus and above the neurites, and thus 
fluorescence in the latter is generally not visible. Staining of 
1HB1 appeared predominantly as a ring of  fluorescence  at the 
periphery of the cell (Fig. 8 F, arrowheads), whereas label- 
ing of both 4HB4 and  1HB4 was most highly concentrated 
in the perinuclear region of the cell body (Fig. 8, J  and R, 
small arrows).  Note that  the distribution  of 1HB1 corre- 
sponds nicely to the plasma membrane as demarcated by the 
arrowheads, whereas the central region of the cell is rela- 
tively free of transporter. In contrast, 4HB4 and  1HB4 are 
seen at the tips of the arrows indicative of perinuclear local- 
ization, well separated from the arrowheads indicating the 
Verhey et al. Chimeric Glucose Transporters  143 Figure 7. Localization of the "tagged" chimeras  in NIH 3T3 ceils by labeling of PM sheets. Clones of NIH 3T3 cells stably expressing 
the "tagged" chimeras were either fixed and stained with mAbG3 for indirect immunofluorescence (A, D, G, and J) or were sonified to 
prepare sheets of PM. These were labeled with mAbG3 and rhodamine-conjugated goat anti-rabbit antibody (B, E, H, and K) and with 
FITC conjugated to WGA (C, F, L and L). For each antibody, the same photographic and printing conditions were used for each chimera. 
The cells used in this experiment represent different clonal lines than those shown in Fig. 6, but express approximately the same steady 
state level of chimeric  transporter (see Fig. 5). Bar, 20/zM. 
cell  surface.  The  chimera 4HB1  again exhibited  an  inter- 
mediate phenotype, showing staining at the cell periphery as 
well as in the perinuclear region of the cells (Fig.  8 N). 
Discussion 
Although quite similar in primary sequence and predicted 
secondary structure, the glucose transporter isoforms GLUTI 
and GLUT4 are targeted to distinct subcellular locations (4). 
The unique  intracellular  sequestration of GLUT4,  critical 
for insulin-stimulated glucose uptake in muscle and adipose 
tissue, is recapitulated in numerous cell types into which the 
transporter  has  been  introduced  by  DNA-mediated  gene 
transfer (12,  17, 23, 26).  This provides strong evidence that 
intrinsic differences between GLUT1 and GLUT4 are recog- 
nized by the trafficking machinery of the nondifferentiated 
cell.  As an initial  step towards identifying amino acid  se- 
quences  which  dictate isoform-specific targeting,  we have 
studied  the  subcellular  distribution  of chimeric  GLUT1/ 
GLUT4 transporters stably expressed in two unrelated cell 
lines. Our results strongly suggest that at least two discon- 
tinuous domains disproportionately contribute to the differ- 
ential sorting of these isoforms. 
At the onset of these studies, it seemed likely that substan- 
tial care was required to avoid several obvious, potential ar- 
tifacts.  In spite of the  remarkable sequence  similarity be- 
tween GLUT1 and GLUT4 (65 % amino acid identity), the 
formal possibility remained that a chimeric transporter could 
assume  a  configuration  which  conferred  novel  targeting, 
resulting in a distribution different from either of the parental 
The Jourrtal of Cell Biology, Volume 123, 1993  144 Figure 8. Indirect immunofluorescence and labeling  of PM sheets of "tagged" chimeras expressed  in PC12 cells.  Parental PC12 cells and 
pools of PC12 cells stably infected with retrovirus containing the cDNAs of the "tagged" chimeras were treated with NGF, fixed, permeabi- 
lized, and stained with mAbG3 and rhodamine-conjugated goat anti-mouse antibody, and were analyzed by indirect immunofluorescence 
(A, E, L M, and Q) and by laser scanning confocal microscopy (B, F, J, N, and R). The periphery of the ceils was visualized  by labeling 
of the cell surface with FITC-WGA and is indicated  in the figure by arrowheads.  Phase micrographs were used to determine the location 
of the margins of the nuclei, which are indicated  by small arrows overlying the nuclei and pointing outward.  The same cells were sonified 
to prepare sheets of PM, which were fixed and labeled  with mAbG3 and rhodamine--conjugated goat anti-mouse antibody (C, G, K, O, 
and S) and with FITC conjugated to WGA (D, H, L, P, and T). For each antibody and assay, the same photographic and priming conditions 
were used for all chimeras.  Bars,  20 #M. 
wild-type transporters.  Several  precautions  were  taken  to 
minimize this  likelihood.  First,  in all  cases reciprocal do- 
mains  were exchanged between  isoforms and the resultant 
chimeras were compared in similar cellular contexts.  Sec- 
ond, the mutagenesis strategy employed was such that in no 
instance  was an amino acid residue  introduced into a  chi- 
mera that was not present in a wild-type transporter.  Lastly, 
the chimeric transporters  were expressed  in two divergent 
cell types: an undifferentiated fibroblast line and a neuroen- 
docrine cell line with a  well-developed regulated secretory 
pathway. Although NIH 3T3 cells clearly direct GLUT1 and 
GLUT4 to different subcellular locations, it was possible that 
the  "intermediate"  phenotype  observed  for  some  of  the 
chimeras might have been related to their expression in an 
undifferentiated,  fibroblastic cell type. Recently, Hudson et 
al. (18) have found that the rat neuroendocrine cell line PC12 
targets GLUT4 but not GLUT1 to a regulated secretory com- 
partment, the large dense core granules, as well as to endo- 
somes. Thus, we also evaluated the distributions of the chi- 
meric transporters  in PC12 cells. 
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(Figs. 2 and 3) presented several additional problems. Most 
troublesome was the observation that an apparently domi- 
nant signal for subcellular sorting, the carboxy-terminal 30 
amino acids, overlapped the epitope recognized by antisera 
raised against each isoform. Thus, as targeting could not be 
separated from antibody reactivity, it was impossible to criti- 
cally confirm the role of this domain using a single antise- 
rum. This was particularly worrisome since the carboxy ter- 
minus of  the transporter has been implicated as being subject 
to "epitope masking;  i.e.,  conformational changes which 
affect its immunoreactivity and consequent apparent subcel- 
lular distribution when assayed by microscopy (29). In addi- 
tion, it was clear that the transporters, both wild-type and 
chimeric, tended to be expressed at vastly different levels, 
and it has been suggested that this may influence the resultant 
staining pattern (2,  17). It was therefore deemed necessary 
to compare cell lines expressing relatively similar steady- 
state levels of chimeric transporters, a parameter difficult to 
ascertain with multiple antibodies and, at least for GLUT1, 
in the presence of cross-reacting endogenous transporter. 
The solution to these problems was to "tag  ~ the recombi- 
nant proteins with a nondisruptive neutral epitope, permitting 
the relatively easy selection of clonal cell lines expressing 
similar levels of chimeric transporters, as well as allowing 
a  direct comparison of the staining patterns of reciprocal 
chimeras. To accomplish this without introducing foreign se- 
quences  into  the  recombinant  transporters,  we  used  a 
human-specific mAb which recognizes a region of GLUT1 
in which there is only one, conservative amino acid differ- 
ence between the rat and human transporters. We confirmed 
that changing Arg 239 to His in the rat GLUT1 sequence was 
sufficient to confer reactivity with rnAbG3, and that this an- 
tisera did not detect the transporter endogenous to NIH 3T3 
or PC12 cells (Figs. 4, 5, and 8). The initial experiments sug- 
gested that the site at which the human-specific GLUT1 epi- 
tope was located appeared not to affect targeting (Figs. 2 and 
3). This was confirmed by demonstrating that the subcellular 
distribution of  4HB4 was indistinguishable from that of  wild- 
type GLUT4 in numerous cell types (Figs. 7-9, and data not 
shown). Thus, the construction of the ~uman-tagged  ~ set of 
chimeric transporters (Fig. 1, Group lid served to eliminate 
potential artifacts due to significant  variability in levels of  ex- 
pression and to differences in immunoreactivity at the car- 
boxy terminus. In addition, the similarity in staining patterns 
with antisera directed against different regions of the chi- 
meric transporters reduces the likelihood of"epitope-mask- 
ing" as a confounding factor (Fig. 6). 
The last cause for concern addressed by experiments using 
the "tagged" chimeras was the lack of resolution and conse- 
quent ambiguity of light microscopy (Figs. 2 and 3). Since 
mAbG3 was not an adequate reagent for immunoEM (Hud- 
son, A. W., K. J. Verhey, and M. J. Birnbaum, unpublished 
observations), we chose to use labeling of PM sheets as an 
unambiguous method of assessing cell surface abundance of 
the transporters. This assay led to dramatic differences in the 
immunofluorescence staining of cells expressing equivalent 
amounts of IHB1 and 4HIM (Figs. 8 and 9). 
The clearest localization of the chimeras occurred when 
both the amino-terminal 183 amino acids and the carboxyl- 
terminal 30 amino acids were contributed by the same iso- 
form (chimeras 1411, 4144, IA41, 4A14, 1HB1, and 4HIM). 
Chimeras which contained the amino-terminal 183  amino 
acids of GLUT1  and the last 30  amino acids of GLUT4 
(1444,  1144,  1114, IAI4, and 1HIM) were directed primar- 
ily to the perinuclear region, similar to GLUT4. The recip- 
rocal chimeric transporters,  in which the amino-terminal 
183 amino acids were contributed by GLUT4 and the car- 
boxyl-terminal 30  amino  acids  by  GLUTI  (4441,  4411, 
4111, 4A41, and 4HB1), consistently showed an intermediate 
phenotype, localizing to both the pednuclear region and the 
cell surface. Taken together, these results indicate that the 
cytoplasmic carboxy terminus contains the dominant deter- 
minant of subcellular localization for transporters expressed 
in NIH 3T3 or PC12 cells, but targeting information also re- 
sides in the amino third of the protein. 
Two laboratories have recently reported studies aimed at 
identifying sorting  signals  that distinguish GLUT4  from 
GLUT1.  Piper  et  al.  (23)  expressed  recombinant trans- 
porters in hamster CHO fibroblasts using a  Sindbis virus 
transient expression system. Antibodies directed against the 
carboxy terminus of  each chimera were used to localize them 
by confocal immunofluorescence, EM, and the PM sheet as- 
say.  The  authors  concluded  that  the  amino-terminal  41 
amino acids of GLUT4 are necessary and sufficient for inter- 
cellular sequestration of this transporter.  Asano et al.  (2) 
replaced  the  amino terminus of GLUT4 with  increasing 
amounts of GLUTI, maintaining a GLUT4 carboxy termi- 
nus. Chimeric proteins stably expressed in CHO cells were 
localized by immunofluorescence  and EM using an antibody 
against GLUT4. Two domains were determined to be impor- 
tant for the intraceUular sequestration of GLUT4: one con- 
taining part of MS2 and all of MS3, and a second consisting 
of the carboxy-terminal half of the extracellular loop be- 
tween MS7 and MS8 and all of MS8. We are unable to ex- 
plain with certainty the discrepancies between the two previ- 
ous studies, or between those studies and the data reported 
herein. In contrast to previously published studies, we have 
determined that the carboxy-terminal 30 amino acids of the 
transporter  also  contain  information  dictating  subcellu- 
lar distribution. Replacement of this region of GLUT1 by 
GLUT4 diverted the predominant fraction of the former 
from the plasma membrane to the perinuclear region. Sev- 
eral methodological differences may account for the dis- 
crepancies among these three studies, including the type of 
cell in which the chimeras are expressed and the amount of 
heterologous transporter.  Perhaps the most critical differ- 
ence between this and previous studies is that in the latter the 
majority of relevant chimeras  were  localized exclusively 
with an antibody to the carboxy terminus of GLUT4, and 
thus did not systematically explore the contribution of this 
region to targeting. In experiments using a single antibody 
to  an  epitope  located  in  the  large  cytoplasmic  loop  of 
GLUT1, a  region all investigators agree is not critical for 
isoform-specific targeting, we were able to directly compare 
chimeras  in  which the  only difference was  the  carboxy- 
terminal 30  amino acids.  During  the  preparation  of this 
manuscript, we became aware of two preliminary, indepen- 
dent reports which appear to agree with our findings: the 
carboxy terminus of GLUT4 was found to contain informa- 
tion capable of sequestering chimeric transporters to an in- 
tracellular compartment in CHO cells or Xenopus/aev/s oo- 
cytes (7; Marshall, B., M. Strube, and M. Mueclder. 1993. 
Diabetes.  42(Suppl.).  l:13a). 
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portant for targeting suggests several experimentally testable 
models. One possibility is that these are redundant  signals, 
with both  cooperating  to  ensure  efficient targeting  of the 
transporters.  Alternatively, these two domains may function 
independently at distinct sorting steps carried out in different 
regions of the cell.  Lastly,  these two regions may be jux- 
taposed in the native transporter  to form a single, discon- 
tinuous  sorting  signal.  In  addition  to distinguishing  these 
possibilities,  future experiments will be directed at further 
resolving the critical sequences in each region, as well as de- 
termining their relevance to insulin-stimulated  transporter 
translocation. 
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